Director, Market Access Early Pipeline

Novartis • East Hanover Township, PA

2d • Remote

About The Position

This position can be based remotely anywhere in the U.S. (there may be some restrictions based on legal entity). Please note that this role would not provide relocation as a result. The expectation of working hours and travel (domestic and/or international) will be defined by the hiring manager. This position will require 10% travel. The Director, US Market Access Early Pipeline is part of a team that collectively helps shape the future of Novartis. This role is responsible for market access assumptions to inform how we invest across our pipeline, including choice of indications and key clinical trial design elements. The Director, US Market Access Early Pipeline will be assigned to one of the 4 core disease areas and could be supporting pipeline assets as early as proof as concept through the initiation of the Phase 3 clinical program. Guidance helps to inform asset go/no-go decisions as well as the level of investment required for further development. When assessing assets at proof of concept, this role creates Market Access disease area opportunity assessments to inform R&D focus and establish minimal viable data to support a commercial business case. The Director, US Market Access Early Pipeline works cross-functionally with multiple US and Global stakeholders, including global strategy teams, biomedical research, clinical development, and US commercial teams, to develop a well-supported Market Access disease area strategy that optimizes our ability to reach appropriate patients in the US as well as the overall potential value of the product to the organization.

Requirements

• Education: Bachelor’s degree required; MBA, Health Policy or equivalent preferred
• Minimum of 7 years of pharmaceutical experience in Market Access, Marketing, Managed Care Finance, Insights & Analytics or Business Development
• Awareness and understanding of US healthcare dynamics and the drivers of pharmaceutical value
• Strong interpersonal, communication, and influencing skills combined with an ability to successfully collaborate across a matrix organization
• Ability to analyze complex business issues and trends and to connect commercial, financial, and clinical perspectives to develop enhanced value propositions

Nice To Haves

• Experience in Neuroscience therapeutic area

Responsibilities

• Providing US Market Access forecasting assumptions, including pricing (gross and net), anticipated payer coverage, and the implications of quality of coverage on physician demand and patient Rx fulfillment for assets and indications
• Developing strategies to optimize payer coverage, patient affordability, and sales revenue for assets being considered across multiple indications and therapeutic areas
• Conducting relevant payer market research, analyzing secondary data, and incorporating internal Novartis experience to inform assumptions and recommendations
• Assessing clinical trial designs for potential market access risks and/or opportunities to optimize coverage and patient access (e.g., formulation, dosing, outcomes, potential data that would support positive coverage determinations, choice of comparator, potential cost-offset data)
• Collaborating across multiple teams within the US and Global organizations to create disease area assessments for assets at proof of concept and ensuring that the organization understands what it would take to be commercially successful in different disease areas, including the key criteria needed to support a commercial case and decision to progress an asset into phase 2

Benefits

• US-based eligible employees will receive a comprehensive benefits package that includes health, life and disability benefits, a 401(k) with company contribution and match, and a variety of other benefits.
• In addition, employees are eligible for a generous time off package including vacation, personal days, holidays and other leaves.

What This Job Offers

• Job Type: Full-time
• Career Level: Director
• Number of Employees: 5,001-10,000 employees